BioFuels Journal

Englewood, CO - Feb. 13, 2017 - Gevo, Inc. (NASDAQ:GEVO) announced today that it intends to offer and sell, subject to market and other conditions, Series G units, with each Series G unit consisting of one share of common stock, Series K warrants to purchase a certain number of shares of common stock and Series M warrants to purchase a certain number of shares of common stock.

The Company is also offering Series H units, in lieu of Series G units, to those purchasers whose purchase of additional Series G units in the offering would result in the purchaser beneficially owning more than 4.99% of the Company’s outstanding common stock following the completion of the offering.

The Series H units will consist of pre-funded Series L warrants to purchase one share of common stock, Series K warrants to purchase a certain number of shares of common stock and Series M warrants to purchase a certain number of shares of common stock.

The units are to be sold by Gevo subject to market and other conditions in an underwritten public offering.

Gevo currently intends to use 15% of the net proceeds from the offering, excluding any future proceeds from the exercise of the warrants, to pay down a portion of its outstanding 10% convertible senior secured notes due 2017, with the balance to be used to fund working capital and for other general corporate purposes.

In connection with the offering, Oppenheimer & Co. Inc. is acting as sole book-running manager.

Rodman & Renshaw, a unit of H.C. Wainwright & Co., is acting as co-manager in connection with the offering.

A shelf registration statement relating to the shares of common stock and warrants to be issued in the proposed offering has been filed with the Securities and Exchange Commission (SEC) and is effective.

A preliminary prospectus supplement and accompanying prospectus describing the terms of the proposed offering will be filed with the SEC. Copies of the preliminary prospectus supplement and the accompanying prospectus relating to the securities being offered may also be obtained from Oppenheimer & Co. Inc. Attention: Syndicate Prospectus Department, 85 Broad Street, 26th Floor, New York, NY 10004, or by telephone at (212) 667-8563, or by email at [email protected].

Electronic copies of the preliminary prospectus supplement and accompanying prospectus will also be available on the SEC’s website at www.sec.gov.

This press release does not constitute an offer to sell, or the solicitation of an offer to buy, these securities, nor will there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale is not permitted.

Any offer or sale will be made only by means of a prospectus which has or will be filed with the SEC.

For more information, please contact David Rodewald at 805-494-9508 or [email protected]

See Related Websites/Articles:

• Gevo

more ADVANCED BIOFUELS...